Tag: Diabetes Treatment
From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story
Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a challenge researchers have wrestled with since...
World’s First Once-Weekly Basal Insulin Now in India as Novo Nordisk Launches Awiqli®
In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to 17 years recently diagnosed with stage...